Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
Table 2
Comparison of natural history (NH) cohort with chemotherapy (CT) cohort. 1Performance score–performance score using Zubrod scale, 2OS–overall survival, 3MFS–metastatic-free survival, 4response to CT–response to chemotherapy according to RECIST criteria.